To this end, depleting TAMs, using colony-stimulating factor 1 receptor (CSF1R) blocking antibodies, enhances the activity of PARPi in BRCA1 mutant mouse models of breast cancer [112]. This evidence concerns the gene CSF1R and breast cancer.